Identification of genetic biomarkers for alloimmunization in sickle cell disease

Autor: Sanne M. Meinderts, Jorn J. Gerritsma, Joep W. R. Sins, Martin Boer, Karin Leeuwen, Bart J. Biemond, Anita W. Rijneveld, Jean‐Louis H. Kerkhoffs, Anoosha Habibi, Robin Bruggen, Taco W. Kuijpers, Ellen Schoot, France Pirenne, Karin Fijnvandraat, Michael W. Tanck, Timo K. Berg

Publikováno v: British Journal of Haematology, 186(6), 887-899. Wiley-Blackwell
British Journal of Haematology, 186(6), 887-899. Wiley-Blackwell Publishing Ltd
Meinderts, S M, Gerritsma, J J, Sins, J W R, de Boer, M, van Leeuwen, K, Biemond, B J, Rijneveld, A W, Kerkhoffs, J-L H, Habibi, A, van Bruggen, R, Kuijpers, T W, van der Schoot, E, Pirenne, F, Fijnvandraat, K, Tanck, M W & van den Berg, T K 2019, ' Identification of genetic biomarkers for alloimmunization in sickle cell disease ', British Journal of Haematology, vol. 186, no. 6, pp. 887-899 . https://doi.org/10.1111/bjh.15998
British journal of haematology, 186(6), 887-899. Wiley-Blackwell

Most sickle cell disease (SCD) patients rely on blood transfusion as their main treatment strategy. However, frequent blood transfusion poses the risk of alloimmunization. On average, 30% of SCD patients will alloimmunize while other patient groups f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::883576c61a63042d3aba290ced73375c
https://pubmed.ncbi.nlm.nih.gov/31155710